HEADER TOXIN 11-JAN-16 2NAV TITLE NMR SOLUTION STRUCTURE OF EX-4[1-16]/PL14A COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXENDIN-4, ALPHA/KAPPA-CONOTOXIN PL14A CHIMERA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HELODERMA SUSPECTUM, CONUS PLANORBIS; SOURCE 4 ORGANISM_COMMON: GILA MONSTER, PLANORBIS CONE; SOURCE 5 ORGANISM_TAXID: 8554, 97183 KEYWDS AGONIST, TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.I.SCHROEDER,J.E.SWEDBERG,D.J.CRAIK REVDAT 3 17-AUG-16 2NAV 1 JRNL REVDAT 2 08-JUN-16 2NAV 1 JRNL REVDAT 1 04-MAY-16 2NAV 0 JRNL AUTH J.E.SWEDBERG,C.I.SCHROEDER,J.M.MITCHELL,D.P.FAIRLIE, JRNL AUTH 2 D.J.EDMONDS,D.A.GRIFFITH,R.B.RUGGERI,D.R.DERKSEN,P.M.LORIA, JRNL AUTH 3 D.A.PRICE,S.LIRAS,D.J.CRAIK JRNL TITL TRUNCATED GLUCAGON-LIKE PEPTIDE-1 AND EXENDIN-4 JRNL TITL 2 ALPHA-CONOTOXIN PL14A PEPTIDE CHIMERAS MAINTAIN POTENCY AND JRNL TITL 3 ALPHA-HELICITY AND REVEAL INTERACTIONS VITAL FOR CAMP JRNL TITL 4 SIGNALING IN VITRO. JRNL REF J.BIOL.CHEM. V. 291 15778 2016 JRNL REFN ISSN 0021-9258 JRNL PMID 27226591 JRNL DOI 10.1074/JBC.M116.724542 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NAV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JAN-16. REMARK 100 THE RCSB ID CODE IS RCSB104637. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.6 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.2 MM PROTEIN, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-1H COSY; 2D 1H-15N HSQC; 2D REMARK 210 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, MOLMOL, TOPSPIN, XEASY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 8 10.62 -69.15 REMARK 500 1 ILE A 18 -83.73 -105.95 REMARK 500 2 SER A 8 36.06 -92.39 REMARK 500 2 ILE A 18 -85.16 -86.31 REMARK 500 3 ILE A 18 -81.86 -97.96 REMARK 500 4 ILE A 18 -85.40 -104.22 REMARK 500 5 ILE A 18 -82.59 -100.09 REMARK 500 5 LYS A 21 10.68 83.82 REMARK 500 6 SER A 8 45.50 -81.39 REMARK 500 6 ILE A 18 -72.42 -86.88 REMARK 500 7 ILE A 18 -77.49 -103.74 REMARK 500 8 THR A 5 -61.38 -142.58 REMARK 500 8 PHE A 6 118.24 -168.59 REMARK 500 8 ILE A 18 -77.47 -82.83 REMARK 500 8 CYS A 25 75.75 -117.94 REMARK 500 9 GLU A 3 154.35 69.76 REMARK 500 9 THR A 5 -64.77 -109.64 REMARK 500 9 THR A 7 12.03 -140.98 REMARK 500 9 ILE A 18 -85.11 -93.49 REMARK 500 9 CYS A 25 77.35 -115.65 REMARK 500 10 SER A 8 30.55 -74.19 REMARK 500 10 ILE A 18 -78.32 -94.20 REMARK 500 11 ILE A 18 -88.93 -96.11 REMARK 500 12 ILE A 18 -78.74 -94.00 REMARK 500 13 SER A 8 97.85 163.63 REMARK 500 13 ILE A 18 -87.48 -95.95 REMARK 500 14 GLU A 3 85.68 73.71 REMARK 500 14 SER A 8 35.27 -85.03 REMARK 500 14 LYS A 21 13.94 82.81 REMARK 500 15 ILE A 18 -79.25 -98.54 REMARK 500 15 CYS A 27 -64.00 -140.38 REMARK 500 16 ILE A 18 -79.35 -88.38 REMARK 500 17 THR A 7 -22.41 -147.42 REMARK 500 17 ILE A 18 -84.39 -101.22 REMARK 500 18 GLU A 3 162.63 75.54 REMARK 500 18 THR A 7 14.18 -143.16 REMARK 500 18 ILE A 18 -80.74 -88.61 REMARK 500 18 LYS A 21 9.99 80.91 REMARK 500 19 THR A 7 11.99 -140.76 REMARK 500 19 ASP A 9 99.58 -63.35 REMARK 500 19 ILE A 18 -73.38 -83.27 REMARK 500 20 THR A 5 -74.86 -89.56 REMARK 500 20 SER A 8 38.90 -94.32 REMARK 500 20 ILE A 18 -83.71 -102.82 REMARK 500 20 LYS A 21 8.53 81.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25948 RELATED DB: BMRB REMARK 900 RELATED ID: 2NAW RELATED DB: PDB DBREF 2NAV A 1 16 PDB 2NAV 2NAV 1 16 DBREF 2NAV A 17 28 UNP Q0N4U8 CJEA_CONPO 53 64 SEQADV 2NAV NH2 A 29 UNP Q0N4U8 AMIDATION SEQRES 1 A 29 HIS GLY GLU GLY THR PHE THR SER ASP CYS SER LYS GLN SEQRES 2 A 29 CYS GLU GLU GLY ILE GLY HIS LYS TYR PRO PHE CYS HIS SEQRES 3 A 29 CYS ARG NH2 HET NH2 A 29 3 HETNAM NH2 AMINO GROUP FORMUL 1 NH2 H2 N HELIX 1 1 ASP A 9 GLY A 17 1 9 SSBOND 1 CYS A 10 CYS A 25 1555 1555 2.03 SSBOND 2 CYS A 14 CYS A 27 1555 1555 2.02 LINK C ARG A 28 N NH2 A 29 1555 1555 1.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 131 0 1 1 0 0 0 6 0 0 0 3 END